IPO
IPO
Best Performers
Forthcoming Issues
Closed Issues
New Listings
Current Issues
IPO Performance
IPO News
IPO Analysis
Basis of Allotment
Draft Prospectus
  HOME  >  IPO  >   IPO SNAPSHOT
IPO Snapshot    
Achyut Healthcare Ltd.
Issue Open Date 17-Mar-22  
Issue Closing Date 22-Mar-22  
Application Money 100  
Allotment Money  
Price Band 20 -  
Minimium Application No. 6000  
Issue Size (Shares) 1800000  
Market Lot 1.00  
Objective
a) Funding purchases of machineries and equipment.b) General Corporate Purposes.
Category No. of Shares No. of Shares Subscription Ratio
  Offered / Reserved Bid For  
Non-Institutional Investors     1602000   NA  
Qualified Institutional Buyers     60000   NA  
Retail Individual Investors     5754000   NA  
Business Description
We are engaged in trading of Cenzure, Arpimune, Azathioprine IP, Everomimus, Mycophenolate Mofetil USP, Mycophenolate Sodium USP, Sirolimus, Tacrolimus USP, Infrared thermometer, Ascorbic Acid Coated Vitamin C, Calcium carbonate oyster, Cellulose acetate Phtha
more...
Promoter's Holding
Total Share Capital   4461000  
Offered to Public   1800000  
Promoter's Holding (Pre-Issue)   90.28  
Promoter's Holding (Post-Issue)   66.18  
Address
610 Colonade
B/h Iscon Temple
Opposite Iscon
Brts Bus Stand
Iscon – Ambali Road
Ahmedabad ,
Gujarat ,
380058
Phone: 079 4898 2691 / 9825097076 / 9898986846
Email: compliance@achyuthealthcare.com
Website: www.achyuthealthcare.com
Registrar
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B
Plot 31-32
Gachibowli
Financial District
Nanakramguda
Hyderabad
Listed at
BSE
Lead Manager
GYR Capital Advisors Pvt Ltd.
Promoters
Mahendra Chatrabhuj Raycha and Akshit Mahendra Raycha
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Awareness & Information | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.